Samil Pharmaceutical Co., Ltd. operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Samil Pharmaceutical Co., Ltd. with three other
companies in this sector in South Korea:
Hwail Pharmaceutical Company Limited
sales of 102.07 billion Korean Won [US$89.72 million]
(94.52 billion Korean Won [US$83.08 million]
(86.07 billion Korean Won [US$75.65 million]
of which 80%
was Health Functional Food Segment).
Samil Pharmaceutical Co., Ltd. reported sales of 94.60 billion Korean Won (US$83.15 million)
December of 2018.
increase of 2.8%
versus 2017, when the company's sales were 92.04 billion Korean Won.
Despite this increase, sales are still
below the level achieved in 2016, when Samil Pharmaceutical Co., Ltd.
reported sales of 96.76 billion Korean Won.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Samil Pharmaceutical Co., Ltd. had sales
of 89.23 billion Korean Won.